Diabetes & Endocrinology News

'Real-time Experiment': Compounded GLP-1s on Coupon Site Purveyors on coupon sites like Groupon are marketing weight loss programs that include compounded semaglutide and tirzepatide.
Medscape Medical News, December 26, 2023
Europe: Erythritol Laxative Effect, Lead Levels Concerning A new evaluation by the European Food Safety Authority has set a new level for safe consumption of the sweetener while confirming that a warning label will still be necessary.
Medscape Medical News, December 22, 2023
Walking Fast May Help Prevent Type 2 Diabetes An analysis indicates that patients with fairly brisk walking are at a 24% lower risk for type 2 diabetes than those with easy or casual walking.
Medscape Medical News, December 22, 2023
Alert FDA Issues Warning About Counterfeit Ozempic The FDA has seized thousands of counterfeit units of semaglutide.
Medscape Medical News, December 22, 2023
GLP-1s, Antidiabetic Medications Show Safety in Pregnancy New research shows use of the drugs in pregnancy is on the rise, particularly in the United States, and although teratogenic risks appear low, limitations are notable.
Medscape Medical News, December 22, 2023
Can a Healthy Gut Microbiome Prevent Kidney Stones? Patients with kidney stones show key alterations in gut and urinary microbiota compared with those without.
Medscape Medical News, December 22, 2023
How an Obesity Drug Could Help Alcohol Use Disorder Promising preclinical and early clinical data suggest a role for GLP-1 receptor agonist therapy in treating alcohol use disorder.
Medscape Medical News, December 21, 2023
Many Patients With Type 2 Diabetes Stop Meds After a Year Often, patients with type 2 diabetes on second-line medication discontinue their therapy within a year, warn US researchers who highlight the need for new prescribing approaches.
Medscape Medical News, December 21, 2023
US FDA Approves Sweden-based Calliditas' Kidney Disease Drug The U.S. Food and Drug Administration (FDA) granted full approval to Swedish drugmaker Calliditas Therapeutics' drug to treat rare kidney disease IgA Nephropathy (IgAN), the...
Reuters Health Information, December 20, 2023
French Drugmaker Servier Ordered to Pay $471 Million for Mediator Scandal Drugmaker Servier must pay more than 430 million euros ($471 million) in connection with weight-loss pill Mediator, a French court ruled on Wednesday, saying the company was...
Reuters Health Information, December 20, 2023
Thyroidectomy Beneficial but Risky for Hashimoto Disease Unconventional approach leads to improved general health scores but "unacceptably high" 14% complication rate.
Medscape Medical News, December 20, 2023
Obesity Associated With More Severe MIS-C Outcomes Clinicians should consider obesity as a comorbid factor at the clinical presentation of children with MIS-C, according to researchers.
Medscape Medical News, December 20, 2023
Users of Weight Loss Drugs Regain Weight After Stopping Use The research examined users of weekly injections of tirzepatide, which is the active ingredient in Eli Lilly and Co.'s Zepbound.
WebMD Health News, December 19, 2023
Where Is the 'Microbiome Revolution' Headed Next? Famed microbiome researcher Dr Martin J. Blaser shares what he sees as the most promising applications, and the rigorous clinical trials needed to realize them.
Medscape Medical News, December 19, 2023
GLP-1 RAs Associated With Reduced CRC Risk in T2DM The effects were more profound in patients with overweight and obesity in addition to diabetes.
Medscape Medical News, December 19, 2023
GLP-1s Face Off Against Each Other, Weight-Loss Surgery New comparison studies show the popular weight-loss medications might not reduce certain complications as well as surgical interventions, but there's still plenty of positive news surrounding them.
Medscape Medical News, December 19, 2023
ED Visits for Diabetes on the Rise in the US Emergency department visits by adults with diabetes rose by more than 25% since 2012, with the highest rates among Blacks and those aged over 65 years.
Medscape Medical News, December 19, 2023
Alert FDA Updates Labels for Two Cholesterol-Lowering Agents New bempedoic acid and bempedoic acid/ezetimibe labels add primary hyperlipidemia and remove the maximally tolerated statin requirement and statement on the effect on mortality.
Medscape Medical News, December 18, 2023
More Kids Under Age 4 Have Severe Obesity: Study The new data put an end to hopes that childhood obesity was on the retreat following a small decrease from 2010 to 2016.
WebMD Health News, December 18, 2023
Structure's Diabetes Pill Misses Weight-loss Expectations in Mid-stage Trial Structure Therapeutics' diabetes pill missed market expectations for weight loss in a mid-stage trial and fell short of results from a similar treatment from rival Eli...
Reuters Health Information, December 18, 2023
Top 10 Fictional Docs on Streaming TV Both tried-and-true and out-of-the-ordinary holiday gift ideas are offered to those seeking a great present for a physician.
Medscape News Slideshows, December 15, 2023
Rivals Explore Booming Weight-Loss Drug Market Entry Novo Nordisk and Eli Lilly have pulled ahead in the race for a slice of the weight-loss drugs market, expected to be worth $100 billion by the end of the decade.
Reuters Health Information, December 08, 2023
Eli Lilly Obesity Drug Now Available in US Pharmacies
Reuters Health Information, December 05, 2023
Roche Joins Race for Obesity Drugs With $2.7 Billion Carmot Deal Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk and Eli Lilly.
Reuters Health Information, December 04, 2023
Reducing Albumin Improves Kidney and Heart Function The tablet drug finerenone significantly reduces kidney risk in people with type 2 diabetes and also protects heart health, researchers found.
Medscape Medical News, December 04, 2023
Statin Use Remains Low for At-Risk Patients Expanded prescribing guidelines have not boosted statin use among patients who are at risk for atherosclerotic cardiovascular disease.
Medscape Medical News, December 04, 2023
No Benefit of Levothyroxine in Heart Donors New data challenge the common practice of levothyroxine administration in potential heart donors after brain death to preserve heart function and make more hearts available for transplantation.
Medscape Medical News, December 04, 2023
How Gender-Affirming Treatment Affects Erythrocytosis Gender-affirming hormone therapy has been associated with a risk for abnormal blood cell elevation, but a new study finds that it is a lower risk than was previously believed.
Medscape Medical News, December 04, 2023
US Obesity Docs Expect Zepbound to Show Heart Benefit Some leading US obesity specialists say they expect Eli Lilly’s powerful weight-loss drug Zepbound will produce the same or similar heart benefits as Novo Nordisk’s popular Wegovy.
Reuters Health Information, December 01, 2023
Launches of Novo Nordisk's Weight-Loss Drug Wegovy Novo Nordisk is pushing ahead with the launches of weight-loss drug Wegovy in Europe and Asia, even as it struggles to keep up with demand.
Reuters Health Information, December 01, 2023
EU Watchdog Seeks More Safety Data From GLP-1 Drugmakers The EU's drug watchdog will request more data from makers of a class of diabetes and weight-loss drugs including Ozempic and Wegovy to further investigate suicidal thoughts in some patients taking them.
Reuters Health Information, December 01, 2023
Pfizer Drops Twice-Daily Version of Obesity Pill Over Side Effects Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies after most patients dropped out of its midstage trial with high rates of side effects such as nausea and vomiting.
Reuters Health Information, December 01, 2023
Smoking Alters Salivary Microbiota Changes in oral microbiota caused by cigarette smoking could contribute to development of chronic health conditions.
Medscape Medical News, December 04, 2023
Procedures May Ease Postmenopausal Pain Better Than Drugs Postmenopausal women report more significant improvements in chronic pain after procedural interventions when compared with their younger counterparts, despite being notably less likely to use muscle relaxants, TCAs, and benzodiazepines.
Medscape Medical News, December 01, 2023
What Is the Dark Side of GLP-1 Receptor Agonists? Doctors who prescribe this class of medication should be aware of the rare side effects with which it is associated, said an obesity expert.
Medscape Medical News, December 01, 2023
Novo Nordisk Finds Compounded Wegovy Up to 33% Impure Novo Nordisk on Thursday said it sued one compounding pharmacy and refiled a lawsuit against another after finding their products claiming to contain the active ingredient for its in-demand weight-loss drug were impure.
Reuters Health Information, November 30, 2023
Late-Life Increases in Pulmonary Pressure, Hypertension Age-related increases in pulmonary artery systolic pressure occur in concert with worsening left ventricular diastolic dysfunction and contribute to late-life dyspnea, new data show.
Medscape Medical News, November 30, 2023
ACG 2023 Low-Dose Aspirin: No Flares in Pregnant Patients With IBD Low-dose aspirin is recommended for pregnant women who are at risk of hypertensive disorders, such as eclampsia, preeclampsia, and gestational diabetes.
MDedge News, November 29, 2023
DMARDs Linked to Reduced Thyroid Disease Incidence In a large Swedish rheumatoid arthritis cohort, the incidence of thyroid disease declines after RA diagnosis vs the general population, with the effect strongest among those treated with anti-rheumatic drugs.
Medscape Medical News, November 29, 2023
More Weight Loss With Mounjaro Than Ozempic: Data Analysis Overweight or obese adults lost more weight and shed pounds faster using Eli Lilly's Mounjaro than those taking Novo Nordisk's popular rival weight loss drug.
Reuters Health Information, November 27, 2023

No Results